Mosanna Therapeutics

Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients.

Board of Directors

Jonathan Talbot

Chief Executive Officer


Pascale Tronche


Klaus Wirth


Volker Geiss


Mike Nordsiek

Product Development

Namkje van der Laan

Clinical Operations